. . . . . . . . . . . . "a(SCHEM:\"Tetradecanoylphorbol acetate\") -| p(HGNC:RCN1)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "In the present study, cells from a poorly differentiated squamous cell carcinoma NPC cell line, CNE2, were stimulated by TPA and proteomics technology was carried out to find protein discrepancies between control and TPA-treated cells. Results revealed that TPA treatment in CNE2 cells could upregulate the expression of \\\"triosephosphate isomerase\\\" and \\\"14-3-3 protein sigma\\\" and downregulate the expression of \\\"reticulocalbin 1 precursor\\\", \\\"nucleophosmin\\\", \\\"mitochondrial matrix protein p1 precursor\\\", and \\\"stathmin\\\"." . . "Selventa" . . . . "2014-07-03T14:32:38.812+02:00"^^ . . .